Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine for minimally invasive pancreatic surgery
2021-002625-20Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Intrathecal morphine with Placebo intrathecal injection (2 arms). Primary endpoint: Cumulative 24-hour morphine consumption post-surgery. Started Jun 2021; status: completed.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2021-002625-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002625-20.